Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Medical Marijuana
  • Medigap Premiums
  • Food Stamp Work Rules
  • Patients in ICE Custody
  • RFK Jr. vs. Congress

TRENDING TOPICS:

  • Medical Marijuana
  • Medigap Premiums
  • Food Stamp Work Rules
  • Patients in ICE Custody
  • RFK Jr. vs. Congress

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Aug 3 2022

Full Issue

Perspectives: Collapse In Antibiotic Development Will Hurt Future Crises

Read recent commentaries about pharmaceutical issues.

The Mercury News: A Cornerstone Of Modern Medicine Is On The Brink Of Collapse

Roughly a century after the first antibiotics revolutionized medicine, the development pipeline for these critical drugs is on the brink of collapse. Without policies to reinvigorate research into newer, more potent antibiotics, the world may soon face another global public health crisis as devastating as COVID-19. (Michelle McMurry-Heath, 8/2)

NBC News: FDA Might Ban Menthol Cigarettes. It's About Time, Especially For Black America

In 2009, Congress took the important step of banning flavored cigarettes that enticed youth to start smoking. However, that landmark legislation contained a significant flaw: a loophole that allowed tobacco companies to continue selling  menthol cigarettes. (Dr. Keith Churchwell, 8/1)

Stat: Paxlovid Rebound Happens. Why And To Whom Are Still A Mystery 

As an emergency department physician in New York, I often field calls about medical issues from family members, friends, and even friends of friends. The latest slew of these, about Paxlovid and rebound Covid-19 has revealed the confusion surrounding this phenomenon for me, my physician colleagues, and at least one Nobel laureate. (Joan Bregstein, 8/2)

Columbus Dispatch: Pharmacy Benefit Managers' Practices Surrounded By Secrecy

Most Americans are blissfully unaware of the complicated intricacies that plague our healthcare system, which often increase the cost of critical care and reduce the availability of life-saving drugs. The commission study is an important step in the right direction. (Ted Strickland, 7/29)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
  • Thursday, April 16
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF